Company Encyclopedia
View More
name
Sysmex
SSMXY.US
Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS. In addition, it offers cancer lymph node metastasis testing systems to detect information to help in diagnosing lymph node metastasis; and lab assay services.
1.400 T
SSMXY.USMarket value -Rank by Market Cap -/-

Financial Score

12/11/2025 Update
B
Health Care EquipmentIndustry
Industry Ranking17/165
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE10.11%B
    • Profit Margin9.36%B
    • Gross Margin53.70%B
  • Growth ScoreC
    • Revenue YoY0.37%C
    • Net Profit YoY-13.64%D
    • Total Assets YoY3.62%C
    • Net Assets YoY4.65%C
  • Cash ScoreC
    • Cash Flow Margin1068.18%B
    • OCF YoY0.37%C
  • Operating ScoreB
    • Turnover0.77B
  • Debt ScoreB
    • Gearing Ratio27.82%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Sysmex Corporation Revises Earnings Guidance for the Year Ending March 31, 2026

    Sysmex Corporation revised earnings guidance for the year ending March 31, 2026. For the year ending March 31, 2026, the company expects net sales of JPY 510,000 million, operating profit of JPY 76,000 million and profit attributable to owners of the parent of JPY 45,000 million or JPY 72.19 per basic share.

    marketscreener·
    US
    SSMXY
    -0.95%
    6869
    0.00%
    marketscreener·
    US
    SSMXY
    -0.95%
    6869
    0.00%

    Sysmex Corporation Announces Dividend for the Second Quarter Ended September 30, 2025, Payable on December 2, 2025

    Sysmex Corporation announced dividend of JPY 18.00 per share for the second quarter ended September 30, 2025 compared to JPY 15.00 per share paid a year ago. Scheduled date for dividend payment: December 2, 2025.

    marketscreener·
    6869
    0.00%
    US
    SSMXY
    -0.95%
    marketscreener·
    6869
    0.00%
    US
    SSMXY
    -0.95%

    Sysmex Corporation Announces Commemorative Dividend for the Second Quarter Ended September 30, 2025, Payable on December 2, 2025

    Sysmex Corporation announced commemorative dividend of JPY 1.00 per share (30th anniversary of listing) for the second quarter ended September 30, 2025. Scheduled date for dividend payment: December 2, 2025.

    marketscreener·
    US
    SSMXY
    -0.95%
    6869
    0.00%
    marketscreener·
    US
    SSMXY
    -0.95%
    6869
    0.00%

    Sysmex Corporation reports 4.1% decrease in net sales for first half of fiscal 2026

    Sysmex Corporation reported a 4.1% decrease in net sales for the first half of fiscal 2026, totaling 232.5 billion yen. Operating profit fell by 25.9% to 33.0 billion yen, while profit before tax declined by 21.7% to 29.9 billion yen. Profit attributable to owners decreased by 26.9% to 19.0 billion yen. Regionally, net sales rose in the Americas (1.5%) and EMEA (5.6%), but fell in Japan (16.1%) and China (20.6%).

    Reuters·
    6869
    0.00%
    US
    SSMXY
    -0.95%
    Reuters·
    6869
    0.00%
    US
    SSMXY
    -0.95%

    Sysmex (TSE:6869) Is Up 5.5% After Goldman Sachs Upgrade on Improved Growth Outlook—Has the Bull Case Changed?

    Goldman Sachs upgraded Sysmex Corporation from Neutral to Buy, citing improved growth prospects after the company reported better quarterly results. Concerns about earnings, particularly in China, are seen as already priced in, making the stock more appealing. The upgrade suggests that Sysmex may have reached an earnings bottom, shifting focus to upcoming earnings releases and regulatory approvals. However, uncertainties remain regarding its China operations and revised earnings guidance, which could lead to volatility. Analysts have differing fair value estimates for Sysmex, indicating varied outlooks on its future performance.

    Simplywall·
    6869
    0.00%
    US
    SSMXY
    -0.95%
    Simplywall·
    6869
    0.00%
    US
    SSMXY
    -0.95%